Other studies, instead, focused on the important role of JCV-specific CD4+ T cells in the control of JCV infection based on the knowledge of the increased risk of PML in AIDS patients with low levels of CD4+ lymphocytes, and in patients with idiopathic CD4+ lymphocytopenia (32). This evidence concerns the gene CD4 and AIDS.